Dycom Industries Expects Q3 Revenues To Be In-line To Modestly Lower Than Q2 – Quick Facts

While reporting financial results for the second quarter on Tuesday, Dycom Industries, Inc. (DY) anticipates contract revenues and margins for the third quarter to range from in-line to modestly lower on a sequential basis for the second quarter, based on … Read more…

After Market Hours: Eloxx Pharmaceuticals, ABM Industries Up; Hertz, Iveric, Adamas Pharm Tank

Eloxx Pharmaceuticals, Inc. (ELOX) – The clinical-stage biopharmaceutical company’s shares surged nearly 50% on Wednesday after-hours trade. The company announced that enrollment in its Phase 2 clinical trial for ELX-02 in cystic fibrosis has been resumed in Israel and Europe … Read more…